PTGER4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.117600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.059000E-01
Normal-vs-Stage2
2.011000E-01
Normal-vs-Stage3
3.015800E-01
Normal-vs-Stage4
3.741400E-01
Stage1-vs-Stage2
8.575800E-01
Stage1-vs-Stage3
6.882600E-01
Stage1-vs-Stage4
8.597000E-01
Stage2-vs-Stage3
6.399800E-01
Stage2-vs-Stage4
9.073600E-01
Stage3-vs-Stage4
7.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.820150E-01
Normal-vs-AfricanAmerican
8.744000E-01
Normal-vs-Asian
2.697000E-01
Caucasian-vs-AfricanAmerican
1.368760E-01
Caucasian-vs-Asian
5.705800E-01
AfricanAmerican-vs-Asian
2.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.549230E-01
Normal-vs-Female
3.112200E-01
Male-vs-Female
1.704210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.982000E-01
Normal-vs-Age(41-60Yrs)
3.465800E-01
Normal-vs-Age(61-80Yrs)
1.877170E-01
Normal-vs-Age(81-100Yrs)
1.231220E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.460800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.711400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.487400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.404410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.313780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.833400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.666400E-01
Normal-vs-Daily Drinker
2.505400E-01
Normal-vs-Weekly Drinker
4.292400E-02
Normal-vs-Occasional Drinker
2.795400E-01
Normal-vs-Social Drinker
2.332400E-01
Non Drinker-vs-Daily Drinker
3.636000E-03
Non Drinker-vs-Weekly Drinker
9.466200E-02
Non Drinker-vs-Occasional Drinker
1.364390E-02
Non Drinker-vs-Social Drinker
6.818800E-01
Daily Drinker-vs-Weekly Drinker
4.120000E-01
Daily Drinker-vs-Occasional Drinker
5.443200E-01
Daily Drinker-vs-Social Drinker
4.040000E-02
Weekly Drinker-vs-Occasional Drinker
7.499600E-01
Weekly Drinker-vs-Social Drinker
2.534200E-01
Occasional Drinker-vs-Social Drinker
1.329420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.400400E-01
Normal-vs-Grade 2
4.266400E-01
Normal-vs-Grade 3
5.437200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.725800E-01
Grade 1-vs-Grade 3
9.125000E-01
Grade 1-vs-Grade 4
6.400400E-01
Grade 2-vs-Grade 3
5.276400E-01
Grade 2-vs-Grade 4
4.266400E-01
Grade 3-vs-Grade 4
5.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.416960E-01
Normal-vs-NonDiabetic
1.149780E-01
Diabetic-vs-NonDiabetic
3.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.834590E-01
Normal-vs-NoPancreatitis
1.361170E-01
Pancreatitis-vs-NoPancreatitis
4.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.374600E-01
Normal-vs-N1
1.430610E-01
N0-vs-N1
4.479200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.409800E-02
Normal-vs-TP53-NonMutant
4.749000E-01
TP53-Mutant-vs-TP53-NonMutant
2.814700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
